You will guide a team focused on oral solid dosage forms for Phase I and II, including enabling formulations for poorly soluble compounds—work that directly influences how quickly patients see the benefit of breakthrough therapies
Job Summary
You will guide a team focused on oral solid dosage forms for Phase I and II, including enabling formulations for poorly soluble compounds—work that directly influences how quickly patients see the benefit of breakthrough therapies.
We combine deep disease understanding with digital, data science and AI to better predict clinical success and shorten the path to patients.
We value kindness alongside ambition, and we expect thoughtful challenge as we aim for the greatest and swiftest impact on disease.
Matching Summary
You will guide a team focused on oral solid dosage forms for Phase I and II, including enabling formulations for poorly soluble compounds—work that directly influences how quickly patients see the benefit of breakthrough therapies.
Skills & Requirements
Must-have
Developing oral solid dosage forms
Leading high-performing scientific teams
Formulations for poorly soluble compounds
Cross-functional global collaboration
Quality, SHE and regulatory compliance
Digital, predictive science and automation
Nice-to-have
Experience with GMP clinical supplies
Expertise in enabling technologies
Design of experiments and process modeling
Hands-on automation and data analytics
Managing external CDMO/CRO partnerships
Building inclusive multi-site teams
Key Requirements
At least 10 years pharmaceutical industry experience
BSc, MSc, PhD or equivalent in pharmaceutical science or related field
Proven leadership of scientific teams
Experience in early clinical phase oral solid dosage development
Knowledge of quality, SHE and regulatory requirements
Experience in resource planning and portfolio management